Benzinga’s Top Ratings Upgrades, Downgrades For December 23, 2022
Upgrades For The Toro Co (NYSE:TTC), Raymond James upgraded the previous rating of Market Perform to Outperform. For…
Chardan Capital Initiates Coverage On Anixa Biosciences with Buy Rating, Announces Price Target of $8
Chardan Capital analyst Matthew Barcus initiates coverage on Anixa Biosciences (NASDAQ:ANIX) with a Buy rating and announces Price Target of $8.
Anixa Biosciences Announces Commencement Of Phase 1b Trial Of Its Breast Cancer Vaccine At Cleveland Clinic
Anixa Biosciences, Inc. (NASDAQ:ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today announced the initiation of a Phase 1b trial for its
12 Health Care Stocks Moving In Monday’s After-Market Session
Gainers
Reshape Lifesciences (NASDAQ:RSLS) shares increased by 12.7% to $0.34 during Monday's after-market session. The market value of their outstanding shares is at $1.2 million.
Why Aditxt Shares Dipped Over 58%; Here Are 82 Biggest Movers From Friday
Gainers
Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares jumped 53% to close at $0.58 on Friday.
Anixa Biosciences’ Ovarian Cancer CAR-T Therapy To Be Presented At The Rivkin Center & American Association Of Cancer Research 14th Biennial Ovarian Cancer Research Symposium
Anixa Biosciences, Inc. (NASDAQ:ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today announced that the inventor of its ovarian cancer CAR-T technology, Dr. Jose
Recap Of Monday’s Biotech Catalysts – End Of the Day Summary
Gritstone bio (NASDAQ:GRTS) announced that interim results from the Phase 1/2 trial of GRANITE, its individualized, vaccine-based immunotherapy…
Anixa Initiates Patient Dosing in Initial-Stage Ovarian Cancer Study
Anixa Biosciences (NASDAQ: ANIX) commenced treatment of the first patient in the clinical trial of its novel chimeric antigen receptor T-cell (CAR-T) therapy for ovarian cancer.
70 Biggest Movers From Friday
Gainers
GTY Technology Holdings Inc. (NASDAQ: GTYH) shares climbed 115.2% to close at $6.09 as the company agreed to be acquired by GI Partners.